The Centers for Disease Control and Prevention will be working with the American Pharmacists Association to build infrastructure to expand a program from the National Diabetes Prevention Program within community pharmacies.
Semma Therapeutics has announced the completion of a highly oversubscribed $114 million Series B financing. Proceeds will be used to bring the company’s lead development program of encapsulated stem cell-derived islets, through proof-of-concept in patients while continuing exploration of other regenerative medicine therapeutics.
New Research from the New York University Leonard N. Stern School of Business is highlighting the role that mobile health applications can have on outcomes among patients with diabetes. NYU Stern professor Anindya Ghose and co-authors Beibei Li of Carnegie Mellon University and Citong Guo of the Harbin Institute of Technology found that over 15 months, patients who adopted a Chinese mobile health platform saw a more than 2000% reduction in glucose levels over time, on average.